In radiotherapy-resistant prostate cancer PCa cells, the treatment with the Gal-3 inhibitor modified citrus pectin (MCP) led to radiosensitization of the cells, increasing ROS production and apoptosis (155). Here, LGALS3 is linked to prostate cancer.